Stockpiled vaccines
Many national governments are stockpiling vaccines for biodefense (eg against anthrax) or for general public health purposes (eg pandemic influenza).
Arestat™ technology offers the potential to extend the shelf life for such vaccines. This has the potential for enormous savings and also avoidance of wastage of out-of-date vaccines.
Last updated: 13 June 2008